Close Menu

NEW YORK (GenomeWeb) – Biocept said today that it has signed a distribution agreement for its patented blood collection tubes with global lab product supplier VWR.

Under the terms of the deal, VWR will distribute these blood collection products — which have been validated to preserve ctDNA for up to 96 hours at room temperature — across global markets, except China.

In a statement, Biocept President and CEO Michael Nall said that the agreement marks the first step in Biocept's goal to transform itself from an exclusive CLIA lab business to a technology and products company.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal reports that Russia's announcement of a coronavirus vaccine approval was met with concern as safety testing has not yet been completed.

New Scientist writes there aren't much data available on the accuracy of the two rapid COVID-19 tests the UK plans to roll out.

In PNAS this week: downstream effect of oncoprotein fusion, epigenetic changes influence tRNAs in colon cancer, and more.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.